世界の血清バイオマーカー市場予測（～2028年）：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他

• 英文タイトル：Global Serum Biomarkers Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8959 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

血清バイオマーカー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の血清バイオマーカーの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 血清バイオマーカー市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他 用途別セグメントは次のように区分されます。 ・病院、学術研究機関、外来外科センター、その他 世界の血清バイオマーカー市場の主要な市場プレーヤーは以下のとおりです。 ・Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、血清バイオマーカー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な血清バイオマーカーメーカーの企業概要、2019年～2022年までの血清バイオマーカーの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な血清バイオマーカーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別血清バイオマーカーの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの血清バイオマーカーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での血清バイオマーカー市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および血清バイオマーカーの産業チェーンを掲載しています。 ・第13、14、15章では、血清バイオマーカーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓＆胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他 ・用途別分析2017年-2028年：病院、学術研究機関、外来外科センター、その他 ・血清バイオマーカーの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・血清バイオマーカーのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・血清バイオマーカーのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血清バイオマーカーの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・血清バイオマーカーの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Serum Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Serum Biomarkers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Serum Biomarkers global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hepatocellular Carcinoma Serum Biomarkers segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Serum Biomarkers include Roche, Pfizer, Novartis, Abbott, and BD, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Serum Biomarkers market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Market segment by Application can be divided into
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
The key market players for global Serum Biomarkers market are listed below:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Serum Biomarkers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Serum Biomarkers, with price, sales, revenue and global market share of Serum Biomarkers from 2019 to 2022.
Chapter 3, the Serum Biomarkers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Serum Biomarkers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Serum Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Serum Biomarkers.
Chapter 13, 14, and 15, to describe Serum Biomarkers sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Serum Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Serum Biomarkers Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hepatocellular Carcinoma Serum Biomarkers
1.2.3 Lung Cancer Serum Biomarkers
1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
1.2.5 Breast Cancer Serum Biomarkers
1.2.6 Glioblastoma Serum Biomarkers
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Serum Biomarkers Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Academic & Research Institutes
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Serum Biomarkers Market Size & Forecast
1.4.1 Global Serum Biomarkers Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Serum Biomarkers Sales in Volume (2017-2028)
1.4.3 Global Serum Biomarkers Price (2017-2028)
1.5 Global Serum Biomarkers Production Capacity Analysis
1.5.1 Global Serum Biomarkers Total Production Capacity (2017-2028)
1.5.2 Global Serum Biomarkers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Serum Biomarkers Market Drivers
1.6.2 Serum Biomarkers Market Restraints
1.6.3 Serum Biomarkers Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Serum Biomarkers Product and Services
2.1.4 Roche Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Serum Biomarkers Product and Services
2.2.4 Pfizer Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Serum Biomarkers Product and Services
2.3.4 Novartis Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Serum Biomarkers Product and Services
2.4.4 Abbott Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Serum Biomarkers Product and Services
2.5.4 BD Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Serum Biomarkers Product and Services
2.6.4 Merck Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Serum Biomarkers Product and Services
2.7.4 Eli Lilly Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Serum Biomarkers Product and Services
2.8.4 Agilent Technologies Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Serum Biomarkers Product and Services
2.9.4 Boehringer Ingelheim Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Serum Biomarkers Product and Services
2.10.4 AstraZeneca Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Serum Biomarkers Product and Services
2.11.4 Bristol-Myers Squibb Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Novo Nordisk
2.12.1 Novo Nordisk Details
2.12.2 Novo Nordisk Major Business
2.12.3 Novo Nordisk Serum Biomarkers Product and Services
2.12.4 Novo Nordisk Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Allergan
2.13.1 Allergan Details
2.13.2 Allergan Major Business
2.13.3 Allergan Serum Biomarkers Product and Services
2.13.4 Allergan Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Gilead
2.14.1 Gilead Details
2.14.2 Gilead Major Business
2.14.3 Gilead Serum Biomarkers Product and Services
2.14.4 Gilead Serum Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Serum Biomarkers Breakdown Data by Manufacturer
3.1 Global Serum Biomarkers Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Serum Biomarkers Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Serum Biomarkers
3.4 Market Concentration Rate
3.4.1 Top 3 Serum Biomarkers Manufacturer Market Share in 2021
3.4.2 Top 6 Serum Biomarkers Manufacturer Market Share in 2021
3.5 Global Serum Biomarkers Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Serum Biomarkers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Serum Biomarkers Market Size by Region
4.1.1 Global Serum Biomarkers Sales in Volume by Region (2017-2028)
4.1.2 Global Serum Biomarkers Revenue by Region (2017-2028)
4.2 North America Serum Biomarkers Revenue (2017-2028)
4.3 Europe Serum Biomarkers Revenue (2017-2028)
4.4 Asia-Pacific Serum Biomarkers Revenue (2017-2028)
4.5 South America Serum Biomarkers Revenue (2017-2028)
4.6 Middle East and Africa Serum Biomarkers Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Serum Biomarkers Sales in Volume by Type (2017-2028)
5.2 Global Serum Biomarkers Revenue by Type (2017-2028)
5.3 Global Serum Biomarkers Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Serum Biomarkers Sales in Volume by Application (2017-2028)
6.2 Global Serum Biomarkers Revenue by Application (2017-2028)
6.3 Global Serum Biomarkers Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Serum Biomarkers Sales by Type (2017-2028)
7.2 North America Serum Biomarkers Sales by Application (2017-2028)
7.3 North America Serum Biomarkers Market Size by Country
7.3.1 North America Serum Biomarkers Sales in Volume by Country (2017-2028)
7.3.2 North America Serum Biomarkers Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Serum Biomarkers Sales by Type (2017-2028)
8.2 Europe Serum Biomarkers Sales by Application (2017-2028)
8.3 Europe Serum Biomarkers Market Size by Country
8.3.1 Europe Serum Biomarkers Sales in Volume by Country (2017-2028)
8.3.2 Europe Serum Biomarkers Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Serum Biomarkers Sales by Type (2017-2028)
9.2 Asia-Pacific Serum Biomarkers Sales by Application (2017-2028)
9.3 Asia-Pacific Serum Biomarkers Market Size by Region
9.3.1 Asia-Pacific Serum Biomarkers Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Serum Biomarkers Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Serum Biomarkers Sales by Type (2017-2028)
10.2 South America Serum Biomarkers Sales by Application (2017-2028)
10.3 South America Serum Biomarkers Market Size by Country
10.3.1 South America Serum Biomarkers Sales in Volume by Country (2017-2028)
10.3.2 South America Serum Biomarkers Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Serum Biomarkers Sales by Type (2017-2028)
11.2 Middle East & Africa Serum Biomarkers Sales by Application (2017-2028)
11.3 Middle East & Africa Serum Biomarkers Market Size by Country
11.3.1 Middle East & Africa Serum Biomarkers Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Serum Biomarkers Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Serum Biomarkers and Key Manufacturers
12.2 Manufacturing Costs Percentage of Serum Biomarkers
12.3 Serum Biomarkers Production Process
12.4 Serum Biomarkers Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Serum Biomarkers Typical Distributors
13.3 Serum Biomarkers Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---